Sean Wuxiong Cao - Chief Bus. Development Officer, Director at NovaBridge Biosciences

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Sean Wuxiong Cao in NovaBridge Biosciences

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-21,399
Avg price
$1.99
Total value
-$42,584

Net

Past year
Shares
-21,399
Share %
-100%
Total value
-$42,584

Reported holdings for Sean Wuxiong Cao in NovaBridge Biosciences

Form 4 holding Chief Bus. Development Officer, Director

NovaBridge Biosciences

Security class
Ordinary Shares
Shares / value
35,073
Estimated value
$69,795
Report date
14 May 2026
Price
$1.99
Ownership
Direct
Form 4 holding Chief Bus. Development Officer, Director

NovaBridge Biosciences

Security class
2025 Employee Share Option (right to buy)
Shares / value
181,290
Estimated value
Report date
22 Jun 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Bus. Development Officer, Director

NovaBridge Biosciences

Security class
Restricted Share Units
Shares / value
181,280
Estimated value
Report date
22 Jun 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Transaction history for Sean Wuxiong Cao in NovaBridge Biosciences

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .